MRI Biomarkers for Hand-Motor Outcome Prediction and Therapy Monitoring following Stroke

Figure 1

This graph illustrates the need for prognostic assessment tools, especially for the clinically important subacute stage. In the acute stage, cell death and inflammation are associated with worse outcome, and the therapeutic goal therefore is neuroprotection. In the subacute to chronic stage, neurorehabilitation individually improves clinical outcome.